Norway
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 689.58 M
|
Dec. 31, 2023 | USD 15.98 | -1.62% |
|
Norway |
|
2 |
USD 335.30 M
|
Dec. 31, 2023 | USD 5.71 | 2.33% |
|
Norway |
|
3 |
USD 335.27 M
|
Dec. 31, 2023 | USD 5.88 | -1.04% |
|
Norway |
|
4 |
USD 26.45 M
|
Dec. 31, 2023 | USD 1.21 | 2.68% |
|
Norway |
|
5 |
USD 19.13 M
|
Dec. 31, 2023 | USD 0.17 | -2.50% |
|
Norway |
|
6 |
USD 15.05 M
|
Dec. 31, 2023 | USD 0.57 | 1.53% |
|
Norway |
|
7 |
USD 13.37 M
|
Dec. 31, 2023 | USD 3.46 | 4.14% |
|
Norway |
|
8 |
USD 12.90 M
|
Dec. 31, 2023 | USD 0.23 | 0.44% |
|
Norway |
|
9 |
USD 11.68 M
|
Dec. 31, 2023 | USD 1.20 | -0.29% |
|
Norway |
|
10 |
USD 3.66 M
|
Dec. 31, 2023 | USD 3.42 | 0.44% |
|
Norway |
|
11 |
USD 3.38 M
|
Dec. 31, 2023 | USD 0.54 | -0.84% |
|
Norway |
|
12 |
USD 1.28 M
|
Dec. 31, 2023 | USD 1.36 | 33.77% |
|
Norway |
|
13 |
USD 293.54 K
|
Dec. 31, 2023 | USD 0.11 | -3.45% |
|
Norway |
|
14 |
USD 34.75 K
|
Dec. 31, 2023 | USD 0.77 | -0.80% |
|
Norway |
|
15 |
USD 0.00
|
Dec. 31, 2023 | USD 0.22 | 4.62% |
|
Norway |
|
16 |
USD 0.00
|
Dec. 31, 2023 | USD 0.19 | 2.37% |
|
Norway |
The Biotechnology company in Norway with the highest Revenue is Borregaard ASA (Oslo Stock Exchange: BRG.OL) at USD 689.58 M.
The Biotechnology company in Norway with the lowest Revenue is Ultimovacs ASA (Oslo Stock Exchange: ULTI.OL) at USD 0.00.
The top 10 Biotechnology companies in Norway by Revenue are Borregaard ASA, Aker BioMarine AS, AKVA group ASA, Norcod AS, Hofseth BioCare ASA, Salmon Evolution ASA, Gentian Diagnostics ASA, Nykode Therapeutics AS, ArcticZymes Technologies ASA and Andfjord Salmon AS.
The bottom 10 Biotechnology companies in Norway by Revenue are Ultimovacs ASA, Thor Medical ASA, BerGenBio ASA, PCI Biotech Holding ASA, Lifecare AS, NEXT Biometrics Group ASA, Andfjord Salmon AS, ArcticZymes Technologies ASA, Nykode Therapeutics AS and Gentian Diagnostics ASA.